Wnt/beta-catenin signaling is downregulated in bipolar disorder and riluzole reduces symptoms in this disease (Gould and Manji, 2002; Pittenger et al., 2008; Valvezan and Klein, 2012). Here, CTNNB1 is linked to bipolar disorder.